Showing 271-280 of 8857 results for "".
Dermatology Q&A: New Directions in the Treatment of Hypopigmented Scars
https://practicaldermatology.com/topics/general-topics/dermatology-qa-new-directions-in-the-treatment-of-hypopigmented-scars/21980/A new study shows that off-label use of an unexpected agent yields promising results in the repigmentation of hypopigmented scars.Approvals in Psoriasis and Skin Cancer Highlight a Year of Innovation in Skin Disease Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/approvals-in-psoriasis-and-skin-cancer-highlight-a-year-of-innovation-in-skin-disease-management/21069/After periods of low drug approval rates, the last year brought several new agents to market.Managing Acne and Rosacea in the Aesthetic Patient
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/managing-acne-and-rosacea-in-the-aesthetic-patient/23732/Sometimes patients seeking aesthetic interventions don’t even realize there is help for their inflamed skin.Novel Approaches to Nonmelanoma Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/novel-approaches-to-nonmelanoma-skin-cancer/23696/New and emerging treatment options are advancing care for patients with NMSC.Evolving Perspectives: The Impact of COVID-19 on the Dermatology Market and Consolidation Activity
https://practicaldermatology.com/topics/practice-management/evolving-perspectives-the-impact-of-covid-19-on-the-dermatology-market-and-consolidation-activity/23347/Experts weigh in on the effect of COVID-19 on Mergers & Acquisitions trends in dermatology.What Dermatologists Should Know About Advocacy
https://practicaldermatology.com/topics/practice-management/what-dermatologists-should-know-about-advocacy/23678/The specialty needs advocacy. Here’s why and how to get involved.DermWireTV: Olumiant Approved for AA; Radiesse + Launch; Derms as Influencers; VCS
https://practicaldermatology.com/topics/practice-management/dermwiretv-olumiant-approved-for-aa-radiesse-launch-derms-as-influencers-vcs/20107/Olumiant (baricitinib) from Eli Lilly and Company is approved to treat adult patients with severe alopecia areata. Dermatologists rank as top influencers of consumers’ decisions to have cosmetic procedures, according to results of the American Society for Dermatologic Surgery (ASDS) Consumer SurveyGolden Achievement: Dr. Michael Gold on Lifetime Award at CSF 2016
https://practicaldermatology.com/topics/practice-management/golden-achievement-dr-michael-gold-on-lifetime-award-at-csf-2016/18712/Michael H. Gold, MD was recognized December 2016 at the Cosmetic Surgery Forum in Las Vegas with the Lifetime Contribution to Aesthetics Award by CSF Founder Joel Schlessinger, MD. Speaking about the award, Dr. Gold shares his perspective as a global educator and practitioner (Dr. Gold cofounded theEmerging Business Concept: The Acne Treatment Center
https://practicaldermatology.com/topics/practice-management/emerging-business-concept-the-acne-treatment-center/20700/What if there was a practice devoted solely to the treatment of acne and acne scars?The Best Skincare Products for Eczema, According to Your Peers
https://practicaldermatology.com/topics/atopic-dermatitis/the-best-skincare-products-for-eczema-according-to-your-peers/23747/